Compare NBIX & CNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBIX | CNA |
|---|---|---|
| Founded | 1992 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 12.5B |
| IPO Year | 1996 | N/A |
| Metric | NBIX | CNA |
|---|---|---|
| Price | $151.98 | $46.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 18 | 1 |
| Target Price | ★ $172.33 | $53.00 |
| AVG Volume (30 Days) | ★ 1.1M | 334.8K |
| Earning Date | 10-28-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 8.21% |
| EPS Growth | ★ 12.44 | N/A |
| EPS | ★ 4.19 | 3.66 |
| Revenue | $2,682,700,000.00 | ★ $14,850,000,000.00 |
| Revenue This Year | $23.68 | N/A |
| Revenue Next Year | $18.02 | $21.34 |
| P/E Ratio | $36.30 | ★ $12.78 |
| Revenue Growth | ★ 19.61 | 5.41 |
| 52 Week Low | $84.23 | $43.29 |
| 52 Week High | $157.67 | $51.42 |
| Indicator | NBIX | CNA |
|---|---|---|
| Relative Strength Index (RSI) | 61.79 | 59.38 |
| Support Level | $139.27 | $46.06 |
| Resistance Level | $144.83 | $47.18 |
| Average True Range (ATR) | 4.59 | 0.58 |
| MACD | 0.49 | 0.16 |
| Stochastic Oscillator | 88.14 | 81.38 |
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
CNA Financial Corporation (CNAF) is an insurance holding company that provides commercial property and casualty insurance. The company operates under five segments: Specialty, Commercial and International being its core business, and two segments for its non-core businesses, which are Life and Group and Corporate and Other. CNAF, through its segments, provides professional, financial, specialty property, and casualty products to small businesses and medium-scale organizations. It has its business spread across Continental Europe, United Kingdom, and Canada. The majority of the revenues are generated from the Specialty and Commercial segment of the business.